• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis. Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan

tetano

Editor, Senior Moderator
Emerg Infect Dis. 2020 Apr 27;26(8). doi: 10.3201/eid2608.201192. [Epub ahead of print]
Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan.


Kuo SC, Shih SM, Chien LH, Hsiung CA.

Abstract

Taiwan has strictly followed infection control measures to prevent spread of coronavirus disease. Meanwhile, nationwide surveillance data revealed drastic decreases in influenza diagnoses in outpatient departments, positivity rates of clinical specimens, and confirmed severe cases during the first 12 weeks of 2020 compared with the same period of 2019.



KEYWORDS:

COVID-19; SARS-CoV-2; Taiwan; coronavirus disease; infection control measures; influenza; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses


PMID:32339091DOI:10.3201/eid2608.201192
 
Back
Top Bottom